Actively Recruiting
Creation of a National Multicenter Platform for the Study of Inflammatory Myocardial Disease: Pre-MYO Cohort
Led by Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia · Updated on 2025-03-27
3000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting a national study to better understand patients with suspected myocarditis or inflammatory cardiomyopathy. The study aims to describe the clinical features, management, and biological markers of these patients, including genetic, environmental, and epidemiological factors. It also focuses on validating a new biomarker, hsa-RNA-Chr8:96, for diagnosing myocarditis, and examining how gender, age, and other factors influence disease incidence and severity. This observational study gathers data from a large national group of patients who show symptoms and diagnostic findings compatible with myocarditis or inflammatory cardiomyopathy. Researchers collect clinical information, blood samples, and imaging results to characterize the disease. The study also explores genetic mutations and their interaction with environmental factors to understand patient susceptibility and treatment response. Participants will be followed for up to three years to monitor their clinical condition and biomarker results. Researchers assess symptoms, diagnostic tests, and genetic data to understand disease patterns and validate the new biomarker's accuracy. This long-term follow-up helps study the influence of socio-health and genetic factors on myocarditis outcomes and supports future diagnosis and care improvements.
CONDITIONS
Brief Title
Creation of a National Multicenter Platform for the Study of Inflammatory Myocardial Disease: Pre-MYO Cohort
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Presence of at least one compatible symptom such as acute chest pain, dyspnea on exertion or at rest, unexplained palpitations, arrhythmias, sudden death recovery, or cardiogenic shock
- At least one objective diagnostic finding such as new onset AV block, bundle branch block, ST segment changes, T wave inversion, elevated TnI/TnT, contractility alterations, or positive cardiac MRI criteria
- Patients who have given their informed consent
- Adults aged 18 years or older
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 3 years
Participants with suspected myocarditis or inflammatory cardiomyopathy are observed over time to characterize the condition and study related genetic and environmental factors.
Periodic visits depending on individual assessment
Trial Site Locations
Total: 1 location
1
HCUVA
Murcia, Murcia, Spain, 30120
Actively Recruiting
Research Team
D
Domingo Pascual Figal, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here